[8-K] Twist Bioscience Corporation Reports Material Event

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

8-K

Rhea-AI Filing Summary

CommScope (COMM) Q2-25 10-Q highlights:

Net sales rose 32% YoY to $1.39 bn; H1 sales up 28% to $2.50 bn.
Operating income quadrupled to $236 m on higher volume and improved mix; operating margin expanded to 17.0% (vs. 8.7%).
Continuing-operations EPS turned positive at $0.05 diluted (vs. $(0.34)); total diluted EPS was $0.06.
Discontinued operations added $2.4 m in Q2 and $497 m YTD, chiefly the $490 m after-tax gain on the $2.0 bn sale of the Outdoor Wireless Networks (OWN) segment and DAS unit to Amphenol (closed Jan-25).
Debt deleveraging: divestiture cash plus operations funded $2.05 bn of debt repayment; long-term debt fell to $7.25 bn (-22%).
Liquidity: cash $571 m; H1 operating cash outflow improved to $110 m (vs. $127 m use LY).
Equity position: stockholders鈥� deficit narrowed to $(2.44) bn from $(3.46) bn, aided by FX translation gain (+$229 m YTD).
Segment update: NICS renamed Ruckus; sale of OneCell business on 1 May generated $7 m cash and a $5 m loss (continuing ops).
Risks: interest expense remains heavy at $156 m for the quarter; ANS goodwill headroom only 8%, signalling potential impairment sensitivity; customer concentration鈥擟omcast 14% of sales, Comcast & Anixter 28% of receivables.

Overall, Q2 shows solid topline growth and meaningful balance-sheet repair following strategic divestitures, though leverage and interest burden stay elevated.

CommScope (COMM) 2025雲� 2攵勱赴 10-Q 欤检殧雮挫毄:

靾滊Г於� 鞝勲厔霃欔赴雽€牍� 32% 歃濌皜頃� 13鞏� 9觳滊 雼煬; 靸侂皹旮� 毵れ稖鞚€ 28% 歃濌皜頃� 25鞏� 雼煬.
鞓侅梾鞚挫澋 氍茧焿歃濌皜鞕€ 氙轨姢臧滌劆鞙茧 4氚� 歃濌皜頃� 2鞏� 3,600毵� 雼煬; 鞓侅梾鞚挫澋毳犾潃 17.0%搿� 頇曤寑(鞚挫爠 8.7%).
瓿勳啀鞓侅梾 EPS 頋劃旮办 0.05雼煬搿� 頋戩瀽鞝勴櫂(鞝勲厔霃欔赴 -0.34雼煬); 齑� 頋劃 EPS電� 0.06雼煬.
欷戨嫧鞓侅梾 2攵勱赴鞐� 240毵� 雼煬, 鞐办磮鞚错泟 4鞏� 9,700毵� 雼煬旮办棳, 欤茧 20鞏� 雼煬攴滊鞚� Outdoor Wireless Networks(OWN) 攵€氍� 氚� DAS 鞙犽嫑鞚� Amphenol鞐� 毵り皝頃� 頉� 靹疙泟 4鞏� 9觳滊 雼煬鞚挫澋(2025雲� 1鞗� 膦呺).
攵€毂� 臧愳稌: 毵り皝順勱笀瓿� 鞓侅梾順勱笀鞙茧 20鞏� 5觳滊 雼煬攵€毂� 靸來櫂; 鞛リ赴攵€毂勲姅 72鞏� 5觳滊 雼煬搿� 22% 臧愳唽.
鞙犽彊靹�: 順勱笀 5鞏� 7,100毵� 雼煬; 靸侂皹旮� 鞓侅梾順勱笀頋愲 靾滌湢於� 1鞏� 1觳滊 雼煬搿� 臧滌劆(鞝勲厔 1鞏� 2,700毵� 雼煬靾滌湢於�).
鞛愲掣靸來儨: 欤检＜瓴办啇旮堨澊 24鞏� 4觳滊 雼煬鞝侅瀽鞐愳劀 34鞏� 6觳滊 雼煬鞝侅瀽搿� 於曥唽, 頇橃湪氤€霃� 鞚挫澋 2鞏� 2,900毵� 雼煬搿� 歆€鞗�.
靷梾攵€ 鞐呺嵃鞚错姼: NICS臧€ Ruckus搿� 氇呾弓氤€瓴�; 5鞗� 1鞚� OneCell 靷梾毵り皝鞙茧 700毵� 雼煬順勱笀鞙犾瀰瓿� 500毵� 雼煬靻愳嫟氚滌儩(瓿勳啀鞓侅梾旮办).
鞙勴棙鞖旍澑: 攵勱赴鞚挫瀽牍勳毄 1鞏� 5,600毵� 雼煬搿� 鞐爠頌� 雴掛潓; ANS 鞓侅梾甓� 項る摐耄� 8%搿� 鞛犾灛鞝� 靻愳儊鞙勴棙臁挫灛; 瓿犼皾歆戩霃勨€擟omcast 毵れ稖 14%, Comcast鞕€ Anixter臧€ 毵れ稖毂勱秾鞚� 28% 彀.

鞝勲皹鞝侅溂搿� 2攵勱赴電� 瓴碃頃� 毵れ稖靹膘灔瓿� 鞝勲灥鞝� 毵り皝鞚错泟鞚橂 鞛堧姅鞛甑“ 臧滌劆鞚� 氤挫棳欤茧倶, 鞐爠頌� 雴掛潃霠堧矂毽鞕€ 鞚挫瀽攵€雼挫澊歆€靻嶋悩瓿� 鞛堨潓.

Points cl茅s du 10-Q de CommScope (COMM) pour le T2-25 :

Chiffre d'affaires net en hausse de 32 % en glissement annuel 脿 1,39 milliard de dollars ; ventes du premier semestre en hausse de 28 % 脿 2,50 milliards.
R茅sultat d'exploitation multipli茅 par quatre pour atteindre 236 millions gr芒ce 脿 un volume plus 茅lev茅 et un meilleur mix ; marge d'exploitation port茅e 脿 17,0 % (contre 8,7 %).
BPA des activit茅s poursuivies redevenu positif 脿 0,05 $ dilu茅 (contre -0,34 $) ; BPA dilu茅 total de 0,06 $.
Activit茅s abandonn茅es ont apport茅 2,4 millions au T2 et 497 millions depuis le d茅but de l'ann茅e, principalement la plus-value nette apr猫s imp么ts de 490 millions li茅e 脿 la vente de 2,0 milliards du segment Outdoor Wireless Networks (OWN) et de l鈥檜nit茅 DAS 脿 Amphenol (finalisation en janvier 2025).
D茅sendettement : la tr茅sorerie issue des cessions et les op茅rations ont permis de rembourser 2,05 milliards de dette ; la dette 脿 long terme est pass茅e 脿 7,25 milliards (-22 %).
尝颈辩耻颈诲颈迟茅蝉 : tr茅sorerie de 571 millions ; flux de tr茅sorerie d鈥檈xploitation du premier semestre am茅lior茅 avec une sortie de 110 millions (contre 127 millions l鈥檃n dernier).
Position nette : le d茅ficit des actionnaires s鈥檈st r茅duit 脿 -2,44 milliards contre -3,46 milliards, soutenu par un gain de change de 229 millions depuis le d茅but de l鈥檃nn茅e.
Mise 脿 jour des segments : NICS renomm茅 Ruckus ; la vente de l鈥檃ctivit茅 OneCell le 1er mai a g茅n茅r茅 7 millions de tr茅sorerie et une perte de 5 millions (activit茅s poursuivies).
Risques : les charges d鈥檌nt茅r锚ts restent 茅lev茅es 脿 156 millions pour le trimestre ; la marge de goodwill ANS n鈥檈st que de 8 %, indiquant une sensibilit茅 potentielle 脿 des d茅pr茅ciations ; concentration client 鈥� Comcast repr茅sente 14 % des ventes, Comcast et Anixter 28 % des cr茅ances clients.

Dans l鈥檈nsemble, le T2 montre une croissance solide du chiffre d鈥檃ffaires et une am茅lioration significative du bilan suite 脿 des cessions strat茅giques, bien que l鈥檈ndettement et le poids des int茅r锚ts restent 茅lev茅s.

Insights

TL;DR 鈥� Strong divestiture-fuelled deleveraging offsets high interest cost; core ops momentum positive.

Revenue and gross margin meaningfully expanded, driving a 158% jump in operating income. After applying $2 bn of sale proceeds to repay term loans, net leverage improves by roughly 2脳 EBITDA, easing covenant and refinancing pressure. The OWN/DAS exit also realigns the portfolio toward higher-margin CCS and Ruckus lines. However, with $7.25 bn debt still outstanding and $156 m quarterly interest, sustainable EPS growth depends on further cost actions and cash generation. Guidance was not provided in the filing.

TL;DR 鈥� Credit profile better but leverage, goodwill risk, and customer concentration warrant caution.

Pro forma debt reduction is credit-positive, and liquidity headroom appears adequate. Yet the issuer remains balance-sheet negative and interest coverage is just 1.5脳 (EBIT/interest). ANS goodwill cushion (8%) is thin; any macro softness could trigger impairment, further eroding equity. Large single-customer exposure (Comcast 14% sales, 17% A/R) adds cash-flow volatility. Overall impact is neutral to slightly positive for bondholders.

CommScope (COMM) 2025雲� 2攵勱赴 10-Q 欤检殧雮挫毄:

靾滊Г於� 鞝勲厔霃欔赴雽€牍� 32% 歃濌皜頃� 13鞏� 9觳滊 雼煬; 靸侂皹旮� 毵れ稖鞚€ 28% 歃濌皜頃� 25鞏� 雼煬.
鞓侅梾鞚挫澋 氍茧焿歃濌皜鞕€ 氙轨姢臧滌劆鞙茧 4氚� 歃濌皜頃� 2鞏� 3,600毵� 雼煬; 鞓侅梾鞚挫澋毳犾潃 17.0%搿� 頇曤寑(鞚挫爠 8.7%).
瓿勳啀鞓侅梾 EPS 頋劃旮办 0.05雼煬搿� 頋戩瀽鞝勴櫂(鞝勲厔霃欔赴 -0.34雼煬); 齑� 頋劃 EPS電� 0.06雼煬.
欷戨嫧鞓侅梾 2攵勱赴鞐� 240毵� 雼煬, 鞐办磮鞚错泟 4鞏� 9,700毵� 雼煬旮办棳, 欤茧 20鞏� 雼煬攴滊鞚� Outdoor Wireless Networks(OWN) 攵€氍� 氚� DAS 鞙犽嫑鞚� Amphenol鞐� 毵り皝頃� 頉� 靹疙泟 4鞏� 9觳滊 雼煬鞚挫澋(2025雲� 1鞗� 膦呺).
攵€毂� 臧愳稌: 毵り皝順勱笀瓿� 鞓侅梾順勱笀鞙茧 20鞏� 5觳滊 雼煬攵€毂� 靸來櫂; 鞛リ赴攵€毂勲姅 72鞏� 5觳滊 雼煬搿� 22% 臧愳唽.
鞙犽彊靹�: 順勱笀 5鞏� 7,100毵� 雼煬; 靸侂皹旮� 鞓侅梾順勱笀頋愲 靾滌湢於� 1鞏� 1觳滊 雼煬搿� 臧滌劆(鞝勲厔 1鞏� 2,700毵� 雼煬靾滌湢於�).
鞛愲掣靸來儨: 欤检＜瓴办啇旮堨澊 24鞏� 4觳滊 雼煬鞝侅瀽鞐愳劀 34鞏� 6觳滊 雼煬鞝侅瀽搿� 於曥唽, 頇橃湪氤€霃� 鞚挫澋 2鞏� 2,900毵� 雼煬搿� 歆€鞗�.
靷梾攵€ 鞐呺嵃鞚错姼: NICS臧€ Ruckus搿� 氇呾弓氤€瓴�; 5鞗� 1鞚� OneCell 靷梾毵り皝鞙茧 700毵� 雼煬順勱笀鞙犾瀰瓿� 500毵� 雼煬靻愳嫟氚滌儩(瓿勳啀鞓侅梾旮办).
鞙勴棙鞖旍澑: 攵勱赴鞚挫瀽牍勳毄 1鞏� 5,600毵� 雼煬搿� 鞐爠頌� 雴掛潓; ANS 鞓侅梾甓� 項る摐耄� 8%搿� 鞛犾灛鞝� 靻愳儊鞙勴棙臁挫灛; 瓿犼皾歆戩霃勨€擟omcast 毵れ稖 14%, Comcast鞕€ Anixter臧€ 毵れ稖毂勱秾鞚� 28% 彀.

Points cl茅s du 10-Q de CommScope (COMM) pour le T2-25 :

Chiffre d'affaires net en hausse de 32 % en glissement annuel 脿 1,39 milliard de dollars ; ventes du premier semestre en hausse de 28 % 脿 2,50 milliards.
R茅sultat d'exploitation multipli茅 par quatre pour atteindre 236 millions gr芒ce 脿 un volume plus 茅lev茅 et un meilleur mix ; marge d'exploitation port茅e 脿 17,0 % (contre 8,7 %).
BPA des activit茅s poursuivies redevenu positif 脿 0,05 $ dilu茅 (contre -0,34 $) ; BPA dilu茅 total de 0,06 $.
Activit茅s abandonn茅es ont apport茅 2,4 millions au T2 et 497 millions depuis le d茅but de l'ann茅e, principalement la plus-value nette apr猫s imp么ts de 490 millions li茅e 脿 la vente de 2,0 milliards du segment Outdoor Wireless Networks (OWN) et de l鈥檜nit茅 DAS 脿 Amphenol (finalisation en janvier 2025).
D茅sendettement : la tr茅sorerie issue des cessions et les op茅rations ont permis de rembourser 2,05 milliards de dette ; la dette 脿 long terme est pass茅e 脿 7,25 milliards (-22 %).
尝颈辩耻颈诲颈迟茅蝉 : tr茅sorerie de 571 millions ; flux de tr茅sorerie d鈥檈xploitation du premier semestre am茅lior茅 avec une sortie de 110 millions (contre 127 millions l鈥檃n dernier).
Position nette : le d茅ficit des actionnaires s鈥檈st r茅duit 脿 -2,44 milliards contre -3,46 milliards, soutenu par un gain de change de 229 millions depuis le d茅but de l鈥檃nn茅e.
Mise 脿 jour des segments : NICS renomm茅 Ruckus ; la vente de l鈥檃ctivit茅 OneCell le 1er mai a g茅n茅r茅 7 millions de tr茅sorerie et une perte de 5 millions (activit茅s poursuivies).
Risques : les charges d鈥檌nt茅r锚ts restent 茅lev茅es 脿 156 millions pour le trimestre ; la marge de goodwill ANS n鈥檈st que de 8 %, indiquant une sensibilit茅 potentielle 脿 des d茅pr茅ciations ; concentration client 鈥� Comcast repr茅sente 14 % des ventes, Comcast et Anixter 28 % des cr茅ances clients.

08/04/2025 - 07:21 AM

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

August 4, 2025

Twist Bioscience Corporation

(Exact name of registrant as specified in its charter)

Delaware

001-38720

46-2058888

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I. R. S. Employer

Identification No.)

681 Gateway Boulevard

South San Francisco, CA 94080

(Address of principal executive offices, including ZIP code)

(800) 719-0671

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

Common Stock

TWST

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02Results of Operations and Financial Condition.

On August 4, 2025, Twist Bioscience Corporation (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2025. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information furnished in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01Financial Statements and Exhibits.

(d)Exhibits.


Exhibit No.						Description
99.1						Press release dated August 4, 2025 titled “Twist Bioscience Reports Fiscal Third Quarter 2025 Financial Results”
104						Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: August 4, 2025			Twist Bioscience Corporation

			/s/ Judy Yan
			Judy Yan
			Assistant General Counsel and Assistant Secretary

Source:

AG真人官方